Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Forlì
Clinical trial register · Italy

Clinical Trials in Forlì, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Italy and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 6778 matching records held by the registry are in this view. Synced 08 Oct 2026, 03:19 UTC
6778
Studies in scope
all four open statuses
4069
Recruiting now
open to new participants
1018
Lead sponsors
across recruiting studies
Top sites
Milan 2843 Bologna 1305 Roma 1274 Naples 984 Rome 967
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
IRCCS Azienda Ospedaliero-Universitaria di Bologna3 Kartos Therapeutics, Inc.2 European Institute of Oncology2 University Hospital of Ferrara2 Alexion Pharmaceuticals, Inc.2
Site location
Milan2843 Bologna1305 Roma1274 Naples984 Rome967
All 489 locations
Target enrolment
to

Trials with a site in Forlì

39 of 6778 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Italy
Start
Not yet open
Alexion Pharmaceuticals, Inc.
Phase 3
1,180
Bologna, Forlì, Florence, Rome, Messina, Naples, Padova, Pisa
2027-11-23
Recruiting
Boehringer Ingelheim
Phase 3
466
Catania, Foggia, Forlì, Milan, Monza, Padova, Roma
2026-09-17
Recruiting
A Phase IIb Study to Evaluate AZD8965 in Participants With IPF.
NCT07652658Idiopathic Pulmonary Fibrosis (IPF)
AstraZeneca
Phase 2
359
Foggia, Forlì, Modena, Monza, Pavia, Rozzano, Siena, Torino
2026-06-11
Recruiting
Panuri Performance Study
NCT07587866Pancreatic Ductal Adenocarcinoma (PDAC)
Urteste S.A
Observational
1,100
Forlì, Milan, Pavia, Pisa, Roma, Rozzano
2026-06-10
Recruiting
Liaquat University of Medical & Health Sciences
Not applicable
132
Forlì, Ravenna, Rome, Brescia, Pavia, Turin, Catania, Florence
2026-03-23
Recruiting
Upfront Targeted Axillary Dissection for Luminal Breast Cancer With Limited Axillary Involvement
NCT07278726ALND, Sentinel Lymph Node Biopsy (SLNB), Targeted Axillary Dissection (TAD)
European Institute of Oncology
Observational
150
Bologna, Forlì, Milan, Naples, Ortona, Pavia, Pisa, Roma
2026-01-28
Recruiting
Sexual Well-being of Women Undergoing Mastectomy and Reconstruction
NCT07234461Mastectomy and Breast Reconstruction, Sexual Wellness
European Institute of Oncology
Not applicable
200
Bari, Bologna, Cesena, Forlì, Milan, Olbia, Padova, Palermo
2026-01-21
Recruiting
CatalYm GmbH
Phase 2
131
Forlì, Aviano, Rome, Ravenna
2025-10-07
Not yet open
Evaluating Upper Limb Movement Precision With AuReha in People With One-Sided Motor Impairment
NCT07133100Shoulder Posterior Instability, Shoulder Anterior Instability, Shoulder Anterior Latarjet Instability, Adhesive Capsulitis, Shoulder
DigitalRehab
Not applicable
52
Forlì
2025-10
Recruiting
Alnylam Pharmaceuticals
Phase 3
1,750
Ancona, Bologna, Brescia, Florence, Forlì, Lecce, Milan, Naples
2025-07-02
Recruiting
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
NCT07037459Heart Failure With Preserved Ejection Fraction, Heart Failure With Mildly Reduced Ejection Fraction, Obesity
DrugMaridebart cafraglutide
Amgen
Phase 3
5,056
Bari, Bergamo, Brescia, Cortona AR, Foggia, Forlì, Milan, Naples
2025-06-25
Recruiting
Microplastics and Nanoplastics (MNPs) in Patients With ST-elevation Myocardial Infarction (STEMI)
NCT06965023ST-elevation Myocardial Infarction (STEMI), Microplastics, Nanoplastics, Pollution Exposure
Azienda Ospedaliera "Sant'Andrea"
Observational
130
Roma, Caserta, Catania, Ferrara, Forlì, Milan, Naples, Turin
2025-04-22
Recruiting
Microplastics and Nanoplastics in Patients With Chronic Coronary Syndromes
NCT07291609Chronic Coronary Syndrome, Microplastics, Nanoplastics, Coronary Artery Disease
Azienda Ospedaliera "Sant'Andrea"
Observational
120
Caserta, Forlì, Milan, Naples, Roma, Verona
2025-01-01
Recruiting
Kartos Therapeutics, Inc.
Phase 3
600
Alessandria, Ancona, Bologna, Brescia, Catania, Florence, Forlì, Milan
2024-06-03
Active, closed
Boehringer Ingelheim
Phase 3
1,666
Brescia, Catania, Florence, Foggia, Forlì, Milan, Modena, Monza
2024-05-06
Recruiting
ASST Ovest Milanese
Not applicable
140
Monfalcone, Abbiategrasso, Abano Terme, Arezzo, Forlì, Lucca, Pisa
2024-03-21
Active, closed
Study of ALXN2220 Versus Placebo in Adults With ATTR-CM
NCT06183931Transthyretin Amyloid Cardiomyopathy
DrugCliramitug
Alexion Pharmaceuticals, Inc.
Phase 3
1,181
Bologna, Ferrara, Florence, Forlì, Messina, Milan, Naples, Padova
2024-01-11
Recruiting
United Therapeutics
Phase 3
698
Catania, Forlì, Modena, Monza, Roma, Siena, Verona
2023-10-30
Recruiting
Kartos Therapeutics, Inc.
Phase 2/3
268
Catania, Forlì, Genoa, Lecco, Lucca, Milan, Parma, Piacenza
2023-07-17
Recruiting
Diagnosis and Outcomes of Placental Accretism
NCT06833606Placenta Accreta
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
70
Bologna, Cesena, Forlì, Modena, Parma, Reggio Emilia, Rimini
2023-07-17
Recruiting
AUSL Romagna Rimini
Not applicable
200
Acquaviva delle Fonti, Forlì, Ravenna
2023-05-01
Active, closed
Azienda Usl di Bologna
Not applicable
657
Bologna, Arezzo, Asti, Biella, Ferrara, Forlì, Grosseto, Mirano
2023-05-01
Recruiting
Meyer Children's Hospital IRCCS
Observational
90
Bagno a Ripoli, Borgo San Lorenzo, Forlì, Legnago, Bologna, Bolzano, Cagliari, Empoli
2023-04-05
By invitation
Extension Study of Inhaled Treprostinil in Subjects With Fibrotic Lung Disease
NCT04905693Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease, Progressive Pulmonary Fibrosis
DrugTreprostinil
United Therapeutics
Phase 3
1,850
Modena, Rome, Milan, Catania, Siena, Ancona, Forlì, Roma
2022-09-06
Active, closed
EMD Serono Research & Development Institute, Inc.
Phase 2
256
Bologna, Florence, Forlì, Milan, Misterbianco, Naples, Padova, Pisa
2022-08-17
Active, closed
University Hospital of Ferrara
Not applicable
249
Ferrara, Bologna, Forlì, Palermo, Ravenna, Rimini, Trieste
2021-06-03
Active, closed
Incyte Corporation
Phase 3
899
Bergamo, Brescia, Candiolo, Catania, Forlì, Genoa, Lecce, Milan
2021-05-11
Active, closed
Azienda USL Reggio Emilia - IRCCS
Observational
700
Reggio Emilia, Bologna, Ferrara, Forlì, Modena, Parma, Rimini
2021-05-10
Recruiting
QualiMed Innovative Medizinprodukte GmbH
Observational
198
Rozzano, Forlì, Pavia, Roma
2020-10-03
Recruiting
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
300
Cesena, Forlì, Bologna, Ravenna, Rimini
2020-04-21
Recruiting
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Not applicable
60,000
Meldola (FC), Florence, Forlì, Torino
2020-02-06
Active, closed
Bristol-Myers Squibb
Phase 3
461
Forlì, Milan, Parma
2019-11-05
Not yet open
Hepatocarcinoma Recurrence on the Liver Study - Part2
NCT04053231Liver Cancer, Surgery, Recurrence Tumor, Cirrhosis
University of Milano Bicocca
Observational
3,000
Bari, Bologna, Bolzano, Brescia, Forlì, Lecco, Mantua, Milan
2019-09
Recruiting
Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria
Not applicable
340
Alessandria, Forlì, Camposampiero, Negrar, Acquaviva delle Fonti, Biella, Brescia, Cremona
2018-06-05
Recruiting
Scaffold in Emilia Romagna and in the MAGIC Network
NCT03327961Coronary Artery Disease
University Hospital of Ferrara
Observational
1,111
Agrigento, Treviglio, Bologna, Savigliano, Cona, Forlì, Modena, Parma
2017-12-02
Active, closed
A Phase 3 Study of Pacritinib in Patients With Primary Myelofibrosis, Post Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocythemia Myelofibrosis
NCT03165734Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis
DrugPacritinib
Swedish Orphan Biovitrum
Phase 3
407
Bari, Bologna, Brescia, Florence, Forlì, Milan, Monza, Naples
2017-06-26
Active, closed
Bristol-Myers Squibb
Phase 3
1,314
Arezzo, Faenza, Forlì, Grosseto, Milan, Naples
2017-03-24
Recruiting
Acute Myocardial Infarction: Prognostic and Therapeutic Evaluation
NCT03883711Acute Coronary Syndrome, Myocardium; Injury
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
11,000
Bologna, Forlì
2017-01-01
Active, closed
Astellas Pharma Global Development, Inc.
Phase 2
900
Faenza (RA), Arezzo, Candiolo, Cremona, Forlì, Roma, Toscana, Trento
2016-12-22
Rows per page Showing 1–39 of 39
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Italian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 10 October 2026. https://priyalifescience.com/clinical-trials-italy/city/forl

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Italy and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 6,778 studies in total at the last sync on 08 Oct 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 39 of those studies with a site in Forlì.

How many clinical trials are recruiting in Forlì?

24 of the 39 studies on this page are recruiting new participants as of the 08 Oct 2026, 03:19 UTC sync. A further 3 have not yet opened recruitment, 11 are active but closed to new participants, and 1 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Forlì), 39 studies
PhaseStudiesRecruitingShare
Phase 313533.3%
Observational121030.8%
Not applicable9623.1%
Phase 24210.3%
Phase 2/3112.6%

Most active sponsors

Lead sponsors with the most studies (Forlì)
Lead sponsorStudiesRecruiting
IRCCS Azienda Ospedaliero-Universitaria di Bologna33
Alexion Pharmaceuticals, Inc.20
Azienda Ospedaliera "Sant'Andrea"22
Boehringer Ingelheim21
Bristol-Myers Squibb20
European Institute of Oncology22
Kartos Therapeutics, Inc.22
United Therapeutics21
University Hospital of Ferrara21
Alnylam Pharmaceuticals11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.